<DOC>
	<DOCNO>NCT02216149</DOCNO>
	<brief_summary>Fluoropyrimidine chemotherapy agent , 5-fluorouracil capecitabine , occasionally associate cardiac toxicity . Clinical fluoropyrimidine cardiotoxicity infrequent , subclinical toxicity may much common . Cardiac toxicity may less frequent S-1 compare 5-fluorouracil capecitabine , head-to-head comparison lack . The purpose study compare 2 measure subclinical coronary artery microvascular dysfunction , coronary flow reserve coronary flow response cold pressor test , patient population treat adenocarcinoma gastrointestinal tract one 2 oxaliplatin-containing regimen , either oxaliplatin plus S-1 oxaliplatin plus capecitabine .</brief_summary>
	<brief_title>Effects S-1 Capecitabine Coronary Artery Blood Flow</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Has give write informed consent . Is least 18 year age . Has advance metastatic gastrointestinal tract adenocarcinoma . No previous cancer chemotherapy cancer . Measurable evaluable lesion accord RECIST v1.1 criterion . Is able take medication orally . Has ECOG performance status 0 1 . Has life expectancy least 3 month . Has adequate organ function . Cancer consider operable without prior chemotherapy . Prior chemotherapy cancer . Previous therapy fluoropyrimidines anthracyclines indication . Inability swallow tablet . Known brain metastasis leptomeningeal metastasis . History myocardial infarction , coronary stenting/graft . History unstable angina , coronary/peripheral artery bypass graft . History cerebrovascular accident transient ischemic attack . History pulmonary embolism deep vein thrombosis . Symptomatic congestive heart failure . Ongoing cardiac dysrhythmias . Patients cardiac disease require regular medication . Hypertensive crisis severe hypertension control . Is pregnant lactate female . The cardiac arterial flow test do .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>fluoropyrimidine</keyword>
	<keyword>S-1</keyword>
	<keyword>Teysuno</keyword>
	<keyword>oxaliplatin</keyword>
	<keyword>coronary artery flow</keyword>
	<keyword>coronary artery dysfunction</keyword>
	<keyword>gastrointestinal tract cancer</keyword>
</DOC>